VARUNÉ Bio

Explore VARUNÉ Bio.

Polar Seas Luminous Coasts
Research & development enquiries

What are you curious about?

Start with

Film credits

Making your next R&D decision clearer.

Use VARUNÉ Bio’s evidence map to connect a material, a result, and a development claim. Build a record your team can investigate and improve.

R&D resource. The worksheet organises a local development record; its worked example is fictional.

The statement you want to make

A useful evidence map begins with one exact sentence and the decision behind it.

A paper can be relevant to a subject without supporting every statement made about that subject. Before adding references, write the proposed wording, identify its audience and explain where it would appear. A technical discussion with a formulator and a statement on a consumer product may raise different questions.

Include the impression created by nearby images or comparisons. Then ask a practical question: what would a reasonable reader believe has been demonstrated? That is the proposition your evidence needs to address.

Make the development decision equally exact. A formulation team might be selecting between two materials, while an investor might be deciding whether a comparative study deserves funding. The same source can contribute differently to those questions. Record the alternative course of action and which observation would change it. This keeps the map from becoming a collection of impressive references without a consequential use. A later wording revision should retain that decision and show why the evidence now carries a narrower or different sentence.

Examine the comparison
RecordWhy it matters
Exact wordingMakes the proposition concrete enough to assess.
Audience and placementIdentifies who will interpret it and in what context.
Intended use and marketDefines questions that may need specialist review.
DecisionExplains whether you are selecting a material, planning work or considering public communication.

(Sub-Working Group on Claims, 2017) | (FDA, n.d.)

Know which material the evidence describes

An ingredient name is a starting point. The preparation, formulation and batch make the record useful.

Record the subject of the evidence and the subject of the proposed statement separately. Is one a crude preparation and the other a purified fraction? Has a material been incorporated into a different vehicle? Are the tested and proposed concentrations actually known?

Use identifiers that make those differences visible. If the relationship is uncertain, leave it uncertain. A shared name should not fill a missing preparation history. The European Commission also makes a separate regulatory point: an INCI entry in CosIng does not itself establish that an ingredient is permitted or approved for use (European Commission, n.d.).

The identity guide provides a practical route through that join. Bring the preparation identifier, solids basis, vehicle and processing record into the evidence map. If a source concerns a free molecule but the proposed material is an intact polymer, identify the relationship rather than imply direct equivalence. The next work item can then address the missing bridge, instead of repeating a source’s favourable result under a shared name.

  • Tested preparation and batch, where available.
  • Proposed ingredient or formulation and intended conditions of use.
  • Known changes in composition, processing or concentration.
  • Unknowns that prevent a meaningful match.

(European Commission, n.d.)

Record what you actually inspected

The strength of an appraisal depends partly on what was available to examine.

Keep the citation or record reference together with a precise location, such as a figure, table or methods section. State whether you inspected the full text and supporting material, an abstract, a supplier summary or no underlying record.

For original work, link the conclusion to its underlying records in your controlled files. For published work, preserve the authors’ reported conditions and limitations. If the material is a hypothetical example, mark it as such at the start. None of these categories can silently substitute for another.

Record disagreements as well as access. A table may differ from a quotient of its reported parameters, or a method may describe a condition differently from a figure caption. Preserve the original values and the unresolved issue; do not silently repair the publication. A supplier or research partner can then see whether the next step is source clarification, a method review or a new experiment. Retrieval date and version help distinguish a genuinely new finding from a corrected record.

Examine the comparison
Access recordedUseful next question
Full text availableWere the relevant methods, results and supporting materials inspected?
Abstract onlyWhich methods or uncertainty cannot yet be assessed?
Supplier summaryCan the underlying study and tested preparation be inspected?
Original research recordCan the observation be traced to the experiment and analysis?
Hypothetical exampleIs it unmistakably excluded from real substantiation?

From a biological function to a material brief.

The application gives the science its next question.

Film credits

Match the system to the question

Write down where the observation was made before deciding where it applies.

Record the model or test surface, preparation state, exposure conditions, comparator and measurement time. Then place the proposed use alongside it. This makes the transfer question visible instead of hiding it inside a broad word such as performance.

For a hydration question, an inert film, a laboratory skin model and a human-use assessment are different evidence contexts. A useful map asks which part of the intended outcome each context addresses and what bridge remains to be established. The worksheet flags a selected laboratory-to-human transfer for review; it does not determine whether that transfer is justified.

A proposed bridge should identify the feature expected to transfer and the feature that might break the inference. A deposited film may inform material exchange without reproducing a skin surface; a cultured-cell response may omit exposure conditions central to an application. Describe the relevant difference, then ask for evidence that can resolve it. The strongest transfer case addresses that specific dependency rather than relying on a general similarity between two systems.

Examine the comparison
Evidence contextQuestion to preserve
Material or inert-surface measurementWhat property was measured under those conditions?
Biological modelWhich aspect of the intended use does this model represent?
Human-use evidenceDoes the population, formulation and use match the proposed statement?

(Sub-Working Group on Claims, 2017)

Separate the observation from its interpretation

Capture the result closely enough that another reader can check it.

Record the endpoint, units, timing, comparison and uncertainty reported in the source. Identify what was independently prepared, sampled or observed. If an effect size, analysis detail or limitation is missing, write “not reported” rather than filling the space with an estimate.

Keep observation and interpretation in separate fields. “The instrument reading changed” is an observation only when the underlying record supports it. What caused that change and what it means for a product are further questions. Reporting guidance should fit the study type; CONSORT, for example, addresses randomised trials and is not a universal score for every experiment (EQUATOR Network, 2025).

Keep negative and incomplete observations in the same record. A measured difference that is small, variable or absent can still change the development decision, but its meaning depends on the precision and comparison. Missing results are not zero effects. An inconclusive experiment should not be described as proof of equivalence, nor removed because a positive paper makes the proposed story easier to tell.

  • What changed, relative to which comparator?
  • How was the endpoint defined and measured?
  • What uncertainty and limitations were reported?
  • Which parts of the conclusion are interpretation rather than direct observation?

(EQUATOR Network, 2025)

Making every inference visible

The important work often sits between the result and the final sentence.

Build a chain from the verified observation to the proposed interpretation, then to the intended material, use and wording. Label each link with the evidence or assumption it depends on. If the chain changes preparation, formulation, model or population, show that change.

This is a map of reasoning, not a hierarchy in which every study must climb the same ladder. The question is whether the particular evidence fits the particular statement. The 2017 technical document on cosmetic claims discusses this relationship as nonbinding working-group best practice; it is not an official Commission position or a product-specific legal decision (Sub-Working Group on Claims, 2017).

Give every inference a possible failure condition. If a mechanism is thought to depend on a particular fraction, a comparison with another fraction could weaken it. If an ingredient effect is expected to survive formulation, loss of the effect in the agreed base changes the claim. This makes the chain useful for study design and investment: it shows where the next expenditure can reduce uncertainty, and where a negative result would redirect the programme.

(Sub-Working Group on Claims, 2017)

An open research resource

Building your evidence map

Organise one proposed statement, its evidence and the next decision. You can leave unknowns visible.

Entries stay in this browser session unless you download or print them. Download before leaving to keep your work. Use non-identifying references for confidential records.

Loading the fictional example replaces the current entries. A new record clears them. Download first if you want to keep your work.

1. The statementWhat do you want a reader to understand?
1. The statement

Use one exact sentence. Include any material benefit implied by surrounding images.

Choose the main audience for this statement.

Context affects how a reader interprets the statement.

Record the jurisdiction to investigate; this does not determine classification or compliance.

2. The material and settingCompare what was tested with what the statement is about.
2. The material and setting

Choose the preparation level actually described in the evidence.

Use a non-identifying code; keep confidential identities in your controlled files.

Choose the preparation level the statement is about.

Record a code and relevant version if known.

Choose unknown unless you can document the relationship.

This describes where evidence was generated, not its quality.

Select the context the proposed statement invites the reader to infer.

Record exposure, material state, time, dose basis and relevant use differences. Unknown is a valid entry.

3. The source and observationRecord what you actually inspected and what remains missing.
3. The source and observation

Distinguish external reports, original records and teaching examples.

Use a citation, DOI, public link or non-identifying private record code. A link does not mean the source was reviewed.

Record the relevant figure, table, page, section or controlled record location.

Choose the materials you inspected, not what you hope to obtain.

State what was measured, when and in which units. Keep practical interpretation separate.

Identify what the comparison can isolate and which alternatives remain.

Record whether a result has actually been inspected.

Enter only verified observations from the record. Do not invent missing numbers.

Include independent units, variability and relevant omissions when reported.

4. The reasoning and next decisionPreserve alternatives, uncertainty and a useful next step.
4. The reasoning and next decision

Name a specific competing explanation and what would distinguish it.

Describe the bridge from tested context to proposed wording. The tool cannot decide whether it is justified.

Write what the inspected record can support. This is a working statement, not approved public wording.

Specify the work item and the decision it would change.

Use a role instead of a private identity in a shareable record.

This is your own record, not verification by this tool.

If a review exists, record a non-identifying controlled reference and its scope.

Unknowns can remain visible. You can download an incomplete record at any time. Entries are not saved when you leave or reload this page.

Look for the explanation that could overturn the story

A strong alternative explanation helps identify the comparison that matters.

Ask what else could produce the observed endpoint. In a film experiment, consider whether ordinary differences in deposited mass, thickness, solids, salts or handling could account for the result. In an assay, ask whether interference or the comparator choice could change its interpretation.

The aim is to specify a discriminating question. “There may be confounders” is too vague to guide work. “Would the difference remain when deposited mass is matched?” identifies a condition that a reviewed design could investigate. The appropriate controls and analysis still depend on the material and method.

Place the strongest plausible alternative beside the preferred hypothesis before selecting the study. Then state which observation would favour one account over the other. A control that changes several important variables can leave the argument unresolved, even if it produces a striking difference. Where matching is impossible, explain the trade-off and use a complementary comparison. That allows a formulation partner to judge whether the test would settle its actual question.

Examine the comparison
Alternative explanationMore useful next question
Different deposited amountWas the comparison made on a suitable matched basis?
Contribution from the vehicleWhat does the vehicle comparison establish?
Measurement interferenceCould the test system register something other than the intended endpoint?
Different preparation historyAre handling and material changes documented well enough to interpret the comparison?

The difference under investigation.

Turn the scientific question into a comparison with a useful output.

Film credits

Keeping use, audience and market in the same record

Evidence and public wording need to be considered together.

A scientific mechanism discussed in a research context can take on a different meaning when used to promote a product. Record the intended use and market rather than treating wording as a final cosmetic edit.

The FDA explains that claims and other aspects of presentation can establish intended use. Its examples include claims about changing melanin production and regenerating cells. These are reasons to seek a product-specific US classification review, not a reason for this worksheet to classify a product automatically. GB, EU and other market decisions also require their own current context (FDA, n.d.).

This context belongs at the beginning of a commercial brief, when the intended function is still being shaped. It can change the evidence needed, the feasible application and the people who should review the work. Keep a research hypothesis and a product statement on separate approval routes. The map should preserve unresolved market-specific questions as next steps; it should not return a classification verdict or a ready-to-publish claim.

  • Describe the use the audience is being invited to expect.
  • Record whether the wording is internal, educational or promotional.
  • Flag unresolved classification or claims questions for the relevant specialist.
  • Keep scientific review and permission to publish as separate decisions.

(FDA, n.d.) | (FDA, n.d.)

Write the statement the record can carry

Narrow wording makes the next research question easier to see.

Begin with the actual subject, system and endpoint. Preserve meaningful conditions and uncertainty. If the source only supports a material-level observation, do not write the missing product-level conclusion into the sentence.

The comparison below is fictional. It shows how to frame the information to retrieve; it does not report an experiment, establish a benefit or provide approved claim language.

If an observation supports a narrower sentence, explain why that sentence is still useful to the intended reader. A preparation-level result may justify a comparison in a relevant formula without justifying a finished-product benefit. A negative result may justify discontinuing the current application, or retaining a narrower role that the experiment actually addressed. State the unresolved bridge and the next evidence decision alongside the wording. Keep the source’s comparison and uncertainty visible instead of replacing them with a general claim of performance. That approach gives a customer or investor a proposition they can interrogate rather than a conclusion they have to accept.

Examine the comparison
Fictional proposed statementWhat the record would need to establish
“This ingredient improves skin hydration.”Which preparation and finished formulation, which users and use conditions, and which relevant evidence support the statement?
“Preparation H-01 showed a change in film mass under the reported laboratory conditions.”The original result, comparator, conditions, units and uncertainty must first be inspected and verified.
“Whether H-01 offers a useful hydration benefit remains an open research question.”A clear distinction between the research question and any established observation.

(Sub-Working Group on Claims, 2017)

The evidence that would change the decision

The best next step addresses a consequential gap.

Turn the largest unresolved inference into a bounded work item. State the question, proposed measure, comparison and decision consequence. If a result could not change the next decision, reconsider whether it is the right work to prioritise.

Give the work item an accountable role and identify what must happen first: access to the source, material characterisation, method review, rights, facilities or a specialist assessment. Keep proposed thresholds and resources visibly provisional until justified. This avoids presenting a research plan as a completed milestone.

The work item should also state its stop or redesign consequence. If the expected difference disappears against the incumbent, the next commitment may change; if the source cannot be reconciled to the available preparation, access or identity work may precede performance testing. A useful study has informative alternatives, not a single acceptable outcome. This turns the map into a customer discussion about what must be learned before a larger project, while retaining provisional methods and costs as plans.

Examine the comparison
GapPossible next decision
Underlying methods unavailableObtain and appraise the full source before selecting the material.
Tested and proposed preparations differEstablish whether a defensible identity relationship exists.
Endpoint does not address intended useDecide which additional evidence context would answer the actual question.
Public wording raises a classification questionObtain the relevant specialist review before using that wording.

A film result is not yet a skin conclusion

Follow one fictional record all the way to its unresolved decision.

Imagine a team considering the sentence “H-01 improves skin hydration”. The only available information is a summary describing a laboratory film test on an inert surface. The underlying methods and results have not been inspected. H-01 is a fictional code, and there are no measurements or Bio results in this example.

The useful outcome is a better decision record: obtain the underlying source, identify the tested preparation, appraise the measurement and only then decide whether a human-use question is worth pursuing. Loading the example into the worksheet preserves those gaps. It does not create evidence.

Suppose the full source later becomes available and shows a real film-mass difference. The record would change from an unavailable result to a verified observation in its stated system; the human-use bridge would remain unresolved. If the difference instead vanishes under a suitable control, that outcome also belongs in the decision record. The example teaches how evidence can narrow or redirect a proposition without pretending that any of these hypothetical observations have occurred.

Examine the comparison
Part of the recordFictional entryConsequence
Source accessSummary onlyUnderlying methods and results remain to be checked.
Tested subjectPreparation H-01Composition and preparation history remain unknown.
SystemInert laboratory surfaceA human-use transfer requires explicit consideration.
Target statementSkin hydration in useThe proposed outcome extends beyond the recorded context.
Actual resultNot availableNo performance conclusion can be entered.
Next decisionAppraise source and identity firstFurther work depends on what that appraisal establishes.

Building a record you can review and share

The worksheet organises your reasoning and identifies selected gaps in the information you enter.

Start blank or load the fictional example. You can leave fields unknown and still download the record. Prompts describe missing information or selected transfer questions; they are not an efficacy score, an evidence-quality rating or approval to publish. An absence of prompts does not establish that the reasoning is complete.

Entries are held in this browser session. Download a JSON copy for your own records or use the print view for a discussion. Keep confidential source documents and identity keys in your controlled files, and use non-identifying references here. Review downloaded files before sharing them.

Use the exported record to structure a scientific or commercial conversation: which preparation matters, which inference is unresolved and what output would justify further work? The worksheet’s usefulness depends on the source appraisal and judgement around it, rather than the number of completed fields. A colleague reviewing the record should be able to identify both the proposed hypothesis and the result that would make the team change direction.

  • One record for one material, intended use and proposed statement.
  • Review prompts alongside the original sources and professional judgement.
  • Record the next decision and its owner.
  • Download before leaving if you want to keep your work.

Bring an R&D brief

A short, non-confidential introduction can outline the application, the current approach, and where scientific input could help. Scope and next steps would be agreed around the actual project.

Discuss the development question

Sources and reading notes.

External work is identified below. Access notes describe the material inspected for this page; company research questions and proposed work are not presented as findings from these sources.

Sub-Working Group on Claims, 2017Sub-Working Group on Claims (2017) Technical document on cosmetic claims, version of 3 July 2017

Best-practice discussion of evidence-to-claim reasoning and avoiding unsupported ingredient-to-product extrapolation.

Scope and limitations: Nonbinding working-group best practice; explicitly not an official Commission position or legal determination. PDF text accessed; no human regulatory review completed.

Original fifteen-page PDF scope, authorship and evidence-to-claim passages rechecked · Source checked 2026-10-14

Open original source
European Commission, n.d.European Commission (n.d.) Cosmetic ingredient database: CosIng and ingredient-name limitations

INCI/CosIng entries do not themselves establish permission or approval.

Scope and limitations: No specific Bio material queried or authorised; substance-specific checks remain required.

official web page · Source checked 2026-10-14

Open original source
FDA, n.d.FDA (n.d.) Is It a Cosmetic, a Drug, or Both? (Or Is It Soap?)

Intended-use classification and examples including sun protection, melanin-production and cell-regeneration claims.

Scope and limitations: Federal overview; current drug routes, state law and product-specific advice are outside this determination.

official web page · Source checked 2026-10-14

Open original source
FDA, n.d.FDA (n.d.) Cosmetics Labeling Claims

Truthful labelling and intended-use claims.

Scope and limitations: Not a review of any Bio label, advertisement or product.

official web page · Source checked 2026-10-14

Open original source
EQUATOR Network, 2025EQUATOR Network (2025) CONSORT 2025 Statement: updated guideline for reporting randomised trials

Study-type appropriate reporting-checklist entry point for randomised trials.

Scope and limitations: Reporting completeness is not a numerical bias or efficacy score; method must fit study design.

official web page · Source checked 2026-10-14

Open original source